Search

Your search keyword '"Bourlon, Francois"' showing total 26 results
Start Over Author "Bourlon, Francois"
26 results on '"Bourlon, Francois"'

1. TAVR Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist?

Author

Didier, Romain, Lhermusier, Thibault, Auffret, Vincent, Eltchaninoff, Hélène, Le Breton, Herve, Cayla, Guillaume, Commeau, Philippe, Collet, Jean Philippe, Cuisset, Thomas, Dumonteil, Nicolas, Verhoye, Jean Philippe, Beurtheret, Sylvain, Lefèvre, Thierry, Teiger, Emmanuel, Carrié, Didier, Himbert, Dominique, Albat, Bernard, Cribier, Alain, Sudre, Arnaud, Blanchard, Didier, Bar, Olivier, Rioufol, Gilles, Collet, Frederic, Houel, Remi, Labrousse, Louis, Meneveau, Nicolas, Ghostine, Said, Manigold, Thibaut, Guyon, Philippe, Delepine, Stephane, Favereau, Xavier, Souteyrand, Geraud, Ohlmann, Patrick, Doisy, Vincent, Beygui, Farzin, Gommeaux, Antoine, Claudel, Jean-Philippe, Bourlon, Francois, Bertrand, Bernard, Iung, Bernard, and Gilard, Martine

Published
2021
Full Text
View/download PDF

2. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry

Author

Didier, Romain, Eltchaninoff, Hélène, Donzeau-Gouge, Patrick, Chevreul, Karine, Fajadet, Jean, Leprince, Pascal, Leguerrier, Alain, Lièvre, Michel, Prat, Alain, Teiger, Emmanuel, Lefevre, Thierry, Tchetché, Didier, Carrié, Didier, Himbert, Dominique, Albat, Bernard, Cribier, Alain, Sudre, Arnaud, Blanchard, Didier, Rioufol, Gilles, Collet, Frederic, Houel, Remi, Dos Santos, Pierre, Meneveau, Nicolas, Ghostine, Said, Manigold, Thibaut, Guyon, Philippe, Cuisset, Thomas, Le Breton, Herve, Delepine, Stephane, Favereau, Xavier, Souteyrand, Geraud, Ohlmann, Patrick, Doisy, Vincent, Lognoné, Thérèse, Gommeaux, Antoine, Claudel, Jean-Philippe, Bourlon, Francois, Bertrand, Bernard, Iung, Bernard, and Gilard, Martine

Published
2018
Full Text
View/download PDF

7. Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients

Author

Gilard, Martine, Eltchaninoff, Hélène, Iung, Bernard, Donzeau-Gouge, Patrick, Chevreul, Karine, Fajadet, Jean, Leprince, Pascal, Leguerrier, Alain, Lievre, Michel, Prat, Alain, Teiger, Emmanuel, Lefevre, Thierry, Himbert, Dominique, Tchetche, Didier, Carrié, Didier, Albat, Bernard, Cribier, Alain, Rioufol, Gilles, Sudre, Arnaud, Blanchard, Didier, Collet, Frederic, Santos, Pierre Dos, Meneveau, Nicolas, Tirouvanziam, Ashok, Caussin, Christophe, Guyon, Philippe, Boschat, Jacques, Le Breton, Herve, Collart, Frederic, Houel, Remi, Delpine, Stephane, Souteyrand, Geraud, Favereau, Xavier, Ohlmann, Patrick, Doisy, Vincent, Grollier, Gilles, Gommeaux, Antoine, Claudel, Jean-Philippe, Bourlon, Francois, Bertrand, Bernard, Van Belle, Eric, and Laskar, Marc

Published
2012
Full Text
View/download PDF

10. Percutaneous closure of a paravalvular prosthetic mitral leak complicated by need for acute hemodialysis.

Author

Sozzi, Fabiola, Hugues, Nicolas, Schiavone, Marco, Levy, Frank, Civaia, Filippo, Iacuzio, Laura, Rossi, Philippe, Carugo, Stefano, Bourlon, Francois, and Eker, Armand

Abstract

A case of a severe paravalvular mechanical mitral prosthesis leak (PVL) in a high‐risk surgical patient, complicated with acute heart failure at presentation is described. Considering the high surgical risk and the specific echocardiographic features that would prevent the interventional cardiologist to have a direct access to the PVL with a traditional vascular plug or duct occluder, a percutaneous PVL closure with an Amplatzer‐Amulet (Abbott, Abbott Park, Illinois, United States) LAA device (28 mm) was chosen for the contiguity of the PVL to the left atrial appendage (LAA). A new‐onset hemolysis post‐PVL closure and severe renal failure requiring hemodialysis occurred after the procedure, treated with surgical device removal and leak suture. To the best of our knowledge, this is the first case that describes the attempt to close a PVL, contiguous to the LAA, using the Amulet device. The attempt to close a PVL with these features with an Amplatzer‐Amulet device, although promising, does not appear completely safe to reach the goal, as in our case. In our opinion, the most important reasons are that specific technical recommendations and broad experiences are lacking. Indeed, specific outcomes of this kind of approach are, to date, still unknown. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

14. Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry

Author

Gilard, Martine, Eltchaninoff, Hélène, Donzeau Gouge, Patrick, Chevreul, Karine, Fajadet, Jean, Leprince, Pascal, Leguerrier, Alain, Lievre, Michel, Prat, Alain, Teiger, Emmanuel, Lefevre, Thierry, Tchetche, Didier, Didier, Didier, Himbert, Dominique, Albat, Bernard, Cribier, Alain, Sudre, Arnaud, Blanchard, Didier, Rioufol, Gilles, Collet, Frederic, Houel, Remi, Dos Santos, Pierre, Meneveau, Nicolas, Ghostine, Said, Manigold, Thibaut, Guyon, Philippe, Grisoli, Dominique, Le Breton, Herve, Delpine, Stephane, Favereau, Xavier, Souteyrand, Geraud, Ohlmann, Patrick, Doisy, Vincent, Grollier, Gilles, Gommeaux, Antoine, Claudel, Claude, Bourlon, Francois, Bertrand, Bernard, Laskar, Marc, Iung, Bernard, Bertrand, Michel, Cassagne, Jean, Boschat, Jacques, Lusson, Jean, Mathieu, Pierre, Logeais, Yves, Bessou, Jean-Paul, Chevalier, Bernard, Farge, Arnaud, Garot, Philippe, Hovasse, Thomas, Morice, Claude, Romano, Mauro, Vahdat, Olivier, Farah, Bruno, Carrie, Didier, Dumonteil, Nicolas, Fournial, Gérard, Bertrand, Marc, Nataf, Patrick, Vahanian, Alec, Leclercq, Florence, Piot, Christophe, Schmutz, Laurent, Aubas, Pierre, du Cailar, A., Dubar, A., Durrleman, N., Fargosz, F., Levy, Gilles, Maupas, Eric, Rivalland, François, Robert, G., Tron, Christophe, Juthier, Francis, Modine, Thomas, Van Belle, Eric, Banfi, Carlo, Sallerin, Thierry, Bar, Olivier, Barbey, Christophe, Chassaing, Stephan, Chatel, Didier, Le Page, Olivier, Tauran, Arnaud, Cao, Daniele, Dauphin, Raphael, Durand de Gevigney, Guy, Finet, Gérard, Jegaden, Olivier, Obadia, François, Beygui, Farzin, Collet, Jean-Philippe, Pavie, Alain, Vaillant, Alain, Vicat, Jacques, Wittenberg, Olivier, Joly, Patrick, Rosario, Roger, Bergeron, Patrice, Bille, Jacques, Gelisse, Richard, Couetil, Jean-Paul, Dubois Rande, Jean-Luc, Hayat, Delphine, Fougeres, Emilie, Monin, Jean-Luc, Mouillet, Gauthier, Arsac, Florence, Choukroun, Emmanuel, Dijos, Marina, Guibaud, Jean-Philippe, Leroux, Lionel, Elia, Nicolas, Chocron, Sidney, Schiele, François, Caussin, Christophe, Azmoun, Alexandre, Nottin, Rémi, Tirouvanziam, Ashok, Crochet, Dominique, Gaudin, Régis, Roussel, Jean-Christian, Bonnet, Nicolas, Digne, Franck, Mesnidrey, Patrick, Royer, Thierry, Stratiev, Victor, Bonnet, Jean-Louis, Cuisset, Thomas, Abouliatim, Issal, Bedossa, Marc, Boulmier, Dominique, Verhoye, Philippe, Delepine, Stéphane, Debrux, Jean-Louis, Furber, Alain, Pinaud, Frédéric, Bezon, Eric, Choplain, Jean-Noel, Bical, Oliver, Dambrin, Grégoire, Deleuze, Philippe, Jegou, Arnaud, Lusson, Jean-René, Azarnouch, Kasra, Durel, Nicolas, Innorta, Andrea, Lienhart, Yves, Roriz, Ricardo, Staat, Patrick, Fabiani, Jean-Noël, Lafont, Antoine, Zegdi, Rachid, Heudes, Didier, Kindo, Michel, Mazzucotelli, Jean-Philippe, Zupan, Michel, Ivascau, Calin, Lognone, Thérèse, Massetti, Massimo, Sabatier, Rémy, Huret, Bruno, Hochart, Philippe, Bouchayer, Damien, Gabrielle, François, Pelissier, Franck, Tremeau, Guillaume, Dreyfus, Gilles, Eker, Armand, Habib, Yakoub, Hugues, Nicolas, Mialhe, Claude, Chavanon, Olivier, Porcu, Paolo, Vanzetto, Gérald, Donzeau-Gouge, Patrick, Didier, Romain, Gommeaux, Bernard, Claudel, Jean-Philippe, Nutrition, obésité et risque thrombotique ( NORT ), Institut National de la Recherche Agronomique ( INRA ) -Aix Marseille Université ( AMU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Nutrition, obésité et risque thrombotique (NORT), Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, predictive analysis, aortic stenosis, risk score, [ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Abstract

International audience; Transcatheter aortic valve replacement (TAVR) has revolutionized management of high-risk patients with severe aortic stenosis. However, survival and the incidence of severe complications have been assessed in relatively small populations and/or with limited follow-up.; This report details late clinical outcome and its determinants in the FRANCE-2 (FRench Aortic National CoreValve and Edwards) registry.; The FRANCE-2 registry prospectively included all TAVRs performed in France. Follow-up was scheduled at 30 days, at 6 months, and annually from 1 to 5 years. Standardized VARC (Valve Academic Research Consortium) outcome definitions were used.; A total of 4,201 patients were enrolled between January 2010 and January 2012 in 34 centers. Approaches were transarterial (transfemoral 73%, transapical 18%, subclavian 6%, and transaortic or transcarotid 3%) or, in 18% of patients, transapical. Median follow-up was 3.8 years. Vital status was available for 97.2% of patients at 3 years. The 3-year all-cause mortality was 42.0% and cardiovascular mortality was 17.5%. In a multivariate model, predictors of 3-year all-cause mortality were male sex (p < 0.001), low body mass index, (p < 0.001), atrial fibrillation (p < 0.001), dialysis (p < 0.001), New York Heart Association functional class III or IV (p < 0.001), higher logistic EuroSCORE (p

Published
2016

15. TREATMENT OF CONGENITAL CORONARY FISTULA

Author

Sozzi, Fabiola, primary, Hugues, Nicolas, additional, Iacuzio, Laura, additional, Bourlon, Francois, additional, Civaia, Filippo, additional, Dreyfus, Gilles, additional, and Dor, Vincent, additional

Published
2017
Full Text
View/download PDF

21. Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients

Author

Gilard, Martine, primary, Eltchaninoff, Hélène, additional, Iung,, Bernard, additional, Donzeau-Gouge, Patrick, additional, Chevreul, Karine, additional, Fajadet, Jean, additional, Leprince, Pascal, additional, Leguerrier, Alain, additional, Lievre, Michel, additional, Prat, Alain, additional, Teiger, Emmanuel, additional, Lefevre, Thierry, additional, Himbert, Dominique, additional, Tchetche, Didier, additional, Carrié, Didier, additional, Albat, Bernard, additional, Cribier, Alain, additional, Rioufol, Gilles, additional, Sudre, Arnaud, additional, Blanchard, Didier, additional, Collet, Frederic, additional, Dos Santos, Pierre, additional, Meneveau, Nicolas, additional, Tirouvanziam, Ashok, additional, Caussin, Christophe, additional, Guyon, Philippe, additional, Boschat, Jacques, additional, Le Breton, Herve, additional, Collart, Frederic, additional, Houel, Remi, additional, Delpine, Stephane, additional, Souteyrand, Geraud, additional, Favereau, Xavier, additional, Ohlmann, Patrick, additional, Doisy, Vincent, additional, Grollier, Gilles, additional, Gommeaux, Antoine, additional, Claudel, Jean-Philippe, additional, Bourlon, Francois, additional, Bertrand, Bernard, additional, Van Belle, Eric, additional, and Laskar, Marc, additional

Published
2013
Full Text
View/download PDF

26. Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry.

Author

Gilard M, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Tchetche D, Carrié D, Himbert D, Albat B, Cribier A, Sudre A, Blanchard D, Rioufol G, Collet F, Houel R, Dos Santos P, Meneveau N, Ghostine S, Manigold T, Guyon P, Grisoli D, Le Breton H, Delpine S, Didier R, Favereau X, Souteyrand G, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Laskar M, and Iung B

Subjects
Aged, 80 and over, Female, France, Humans, Male, Prospective Studies, Registries, Risk Assessment, Time Factors, Treatment Outcome, Aortic Valve Stenosis surgery, Transcatheter Aortic Valve Replacement
Abstract

Background: Transcatheter aortic valve replacement (TAVR) has revolutionized management of high-risk patients with severe aortic stenosis. However, survival and the incidence of severe complications have been assessed in relatively small populations and/or with limited follow-up., Objectives: This report details late clinical outcome and its determinants in the FRANCE-2 (FRench Aortic National CoreValve and Edwards) registry., Methods: The FRANCE-2 registry prospectively included all TAVRs performed in France. Follow-up was scheduled at 30 days, at 6 months, and annually from 1 to 5 years. Standardized VARC (Valve Academic Research Consortium) outcome definitions were used., Results: A total of 4,201 patients were enrolled between January 2010 and January 2012 in 34 centers. Approaches were transarterial (transfemoral 73%, transapical 18%, subclavian 6%, and transaortic or transcarotid 3%) or, in 18% of patients, transapical. Median follow-up was 3.8 years. Vital status was available for 97.2% of patients at 3 years. The 3-year all-cause mortality was 42.0% and cardiovascular mortality was 17.5%. In a multivariate model, predictors of 3-year all-cause mortality were male sex (p < 0.001), low body mass index, (p < 0.001), atrial fibrillation (p < 0.001), dialysis (p < 0.001), New York Heart Association functional class III or IV (p < 0.001), higher logistic EuroSCORE (p < 0.001), transapical or subclavian approach (p < 0.001 for both vs. transfemoral approach), need for permanent pacemaker implantation (p = 0.02), and post-implant periprosthetic aortic regurgitation grade ≥2 of 4 (p < 0.001). Severe events according to VARC criteria occurred mainly during the first month and subsequently in <2% of patients/year. Mean gradient, valve area, and residual aortic regurgitation were stable during follow-up., Conclusions: The FRANCE-2 registry represents the largest database available on late results of TAVR. Late mortality is largely related to noncardiac causes. Incidence rates of severe events are low after the first month. Valve performance remains stable over time., (Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results